DAP12 Constructs and Their Use to Enhance DC Vaccines and Immunotherapies
Copyright © Targeted News Service 2025
2025-04-01
ALEXANDRIA, Virginia, April 8 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., Tampa, Florida has been assigned a patent (No. US 12264184 B2, initially filed Feb. 23, 2022) developed by Erika A. Eksioglu, Tampa, Florida, for "DAP12 constructs and their use to enhance DC vaccines and immunotherapies." . . .